166 related articles for article (PubMed ID: 3490498)
21. [Speech and voice disorders in Parkinson's disease].
Martnez-Sánchez F
Rev Neurol; 2010 Nov; 51(9):542-50. PubMed ID: 20979034
[TBL] [Abstract][Full Text] [Related]
22. The Lee Silverman Voice Treatment (LSVT®) speech therapy in progressive supranuclear palsy.
Sale P; Castiglioni D; De Pandis MF; Torti M; Dall'armi V; Radicati FG; Stocchi F
Eur J Phys Rehabil Med; 2015 Oct; 51(5):569-74. PubMed ID: 26138088
[TBL] [Abstract][Full Text] [Related]
23. The influence of speaking rate on articulatory hypokinesia in parkinsonian dysarthria.
Caligiuri MP
Brain Lang; 1989 Apr; 36(3):493-502. PubMed ID: 2706450
[TBL] [Abstract][Full Text] [Related]
24. Distinct patterns of imprecise consonant articulation among Parkinson's disease, progressive supranuclear palsy and multiple system atrophy.
Tykalova T; Rusz J; Klempir J; Cmejla R; Ruzicka E
Brain Lang; 2017 Feb; 165():1-9. PubMed ID: 27894006
[TBL] [Abstract][Full Text] [Related]
25. Clinical and imaging characterization of progressive spastic dysarthria.
Clark HM; Duffy JR; Whitwell JL; Ahlskog JE; Sorenson EJ; Josephs KA
Eur J Neurol; 2014 Mar; 21(3):368-76. PubMed ID: 24053325
[TBL] [Abstract][Full Text] [Related]
26. Constancy of (acoustic) relative timing measures in phrase-level utterances.
Weismer G; Fennell AM
J Acoust Soc Am; 1985 Jul; 78(1 Pt 1):49-57. PubMed ID: 4019907
[TBL] [Abstract][Full Text] [Related]
27. Speech Prosody Across Stimulus Types for Individuals with Parkinson's Disease.
K-Y Ma J; Schneider CB; Hoffmann R; Storch A
J Parkinsons Dis; 2015; 5(2):291-9. PubMed ID: 25697957
[TBL] [Abstract][Full Text] [Related]
28. Syllabic timing in dysarthria.
Ziegler W; Hartmann E; Hoole P
J Speech Hear Res; 1993 Aug; 36(4):683-93. PubMed ID: 8377481
[TBL] [Abstract][Full Text] [Related]
29. Neural Correlates of Hypokinetic Dysarthria and Mechanisms of Effective Voice Treatment in Parkinson Disease.
Baumann A; Nebel A; Granert O; Giehl K; Wolff S; Schmidt W; Baasch C; Schmidt G; Witt K; Deuschl G; Hartwigsen G; Zeuner KE; van Eimeren T
Neurorehabil Neural Repair; 2018 Dec; 32(12):1055-1066. PubMed ID: 30444176
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic effects of intensive voice treatment (LSVT LOUD
Boliek CA; Fox CM
Int J Speech Lang Pathol; 2017 Dec; 19(6):601-615. PubMed ID: 27705010
[TBL] [Abstract][Full Text] [Related]
31. Parametric quantitative acoustic analysis of conversation produced by speakers with dysarthria and healthy speakers.
Rosen KM; Kent RD; Delaney AL; Duffy JR
J Speech Lang Hear Res; 2006 Apr; 49(2):395-411. PubMed ID: 16671852
[TBL] [Abstract][Full Text] [Related]
32. Acoustic-phonetic contrasts and intelligibility in the dysarthria associated with mixed cerebral palsy.
Ansel BM; Kent RD
J Speech Hear Res; 1992 Apr; 35(2):296-308. PubMed ID: 1573870
[TBL] [Abstract][Full Text] [Related]
33. Speech motor stability in IPD: effects of rate and loudness manipulations.
Kleinow J; Smith A; Ramig LO
J Speech Lang Hear Res; 2001 Oct; 44(5):1041-51. PubMed ID: 11708525
[TBL] [Abstract][Full Text] [Related]
34. Acoustic characteristics of dysarthria associated with cerebellar disease.
Kent RD; Netsell R; Abbs JH
J Speech Hear Res; 1979 Sep; 22(3):627-48. PubMed ID: 502519
[TBL] [Abstract][Full Text] [Related]
35. Acoustic investigation of stress patterns in Parkinson's disease.
Tykalova T; Rusz J; Cmejla R; Ruzickova H; Ruzicka E
J Voice; 2014 Jan; 28(1):129.e1-129.e8. PubMed ID: 24094802
[TBL] [Abstract][Full Text] [Related]
36. A speaking task analysis of the dysarthria in cerebellar disease.
Kent RD; Kent JF; Rosenbek JC; Vorperian HK; Weismer G
Folia Phoniatr Logop; 1997; 49(2):63-82. PubMed ID: 9197089
[TBL] [Abstract][Full Text] [Related]
37. Acoustic analysis of speech tasks performed by three individuals with spinocerebellar ataxia.
Schalling E; Hartelius L
Folia Phoniatr Logop; 2004; 56(6):367-80. PubMed ID: 15557775
[TBL] [Abstract][Full Text] [Related]
38. Cognitive-perceptual examination of remediation approaches to hypokinetic dysarthria.
McAuliffe MJ; Kerr SE; Gibson EM; Anderson T; LaShell PJ
J Speech Lang Hear Res; 2014 Aug; 57(4):1268-83. PubMed ID: 24687031
[TBL] [Abstract][Full Text] [Related]
39. Intonation and speech rate in Parkinson's disease: general and dynamic aspects and responsiveness to levodopa admission.
Skodda S; Grönheit W; Schlegel U
J Voice; 2011 Jul; 25(4):e199-205. PubMed ID: 21051196
[TBL] [Abstract][Full Text] [Related]
40. [Multiple system atrophy speech assessment: study of five cases].
Knopp DB; Barsottini OG; Ferraz HB
Arq Neuropsiquiatr; 2002 Sep; 60(3-A):619-23. PubMed ID: 12244402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
